Business Description
Biostax Corp
NAICS : 325412
SIC : 2834
ISIN : US45252A3059
Description
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.74 | |||||
EV-to-EBITDA | -0.75 | |||||
EV-to-FCF | 8.6 | |||||
Earnings Yield (Greenblatt) % | -135.14 | |||||
FCF Yield % | 1700 |
GF Valueâ„¢
Biostax Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biostax Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 138 days | ||
| Second quarter earnings results for 2026 | 2026-08-03 | In 36 days | ||
| First quarter earnings results for 2026 | 2026-07-06 | In 8 days | ||
| Annual report for 2025 | 2026-06-29 | In 1 day | ||
| General meeting for 2025 | 2026-06-29 | In 1 day | ||
| Third quarter earnings results for 2024 | 2025-04-11 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-08-19 | 0.08 (-14.29%) | ||
| 0.001:1 Stock Split | 2021-05-06 | 13.20 (+0.00%) | ||
| 0.001:1 Stock Split | 2012-02-27 | 9,000.00 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:BTAX
No articles.
Press Release
Articles on Biostax Corp
No articles.